Skip to content

Should Any One Airway Clearance Technique be Recommended for People With Cystic Fibrosis?

A Comparison of Five Airway Clearance Techniques in the Treatment of Adults With Cystic Fibrosis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00890370
Acronym
ACT
Enrollment
75
Registered
2009-04-29
Start date
1999-07-31
Completion date
2003-09-30
Last updated
2009-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Keywords

Cystic fibrosis, Airway clearance

Brief summary

The study was to evaluate the long term effects, over one year, of five airway clearance techniques used by people with cystic fibrosis (active cycle of breathing techniques, autogenic drainage, positive expiratory pressure and oscillating positive expiratory pressure (R-C Cornet and Flutter)). The primary outcome measure was forced expiratory volume in one second (FEV1)and the null hypothesis was that there are no differences among the regimens.

Interventions

Sponsors

Royal Brompton & Harefield NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of cystic fibrosis (genotype or sweat sodium concentration greater than 70 mmol/litre) * Forced expiratory volume in one second greater than or equal to 25% predicted, on assessment for entry to the study.

Exclusion criteria

* Evidence of a current respiratory exacerbation (Thornton et al 2004) * Current severe haemoptysis * Past history of pneumothorax * Awaiting lung / heart-lung transplantation * Pregnancy * Recent (within 3 months) acquisition of Burkholderia cepacia

Design outcomes

Primary

MeasureTime frame
Forced expiratory volume in one second (FEV1)48 weeks

Secondary

MeasureTime frame
Quality of life (Short Form-36 and Chronic Respiratory Questionnaire)48 weeks
Exercise capacity (Modified shuttle test)48 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026